| 29 | -- 2013

(.....): 99, 115 27,

15

018673

6 , 14-17 2013

.....

4

6 |

6 |

7 | .....

7 |

8 | 6 .....

9 |

14 | .....

16 |

18 | (Posters)

21 | 6

22 |

24 |

24 | :

28 | -

28 |

31 | -

31 | (ESCP)

34 | 9 () ,

42 | (TransAtlantic-TACD): - :

27 |

27 |

| 29 - 2013

..... : : . : : : : : , ,

..... 99, 115 27, ./fax: 210 7753104e-mail: pefni@ath.forthnet.grhttp://www.pefni.gr

I

-

K

, , ,

, . . .

: , , ,

:

:PressiousArvanitidis

& :

.: 210 28.29.552, 28.43.871

5 - - 2013

(.....) !

2014

!

6

, 09.12.2013

. .: 507

: 1) . 2) . .. . . :

:

, . ,

.. (.. 112/89 7 . 1 . - 49/10-2-89), - , . - (.. 108/1993, . , ..) . - (, - ..) (.. - , - , ..). -

, - , - . , ..... -, . - . , - - . - .

..

.

.. . . . .

- (). - , () 2014.

. 3580/2007 ( 10 . 3 ) . - , , . (.3846/2010, .3867/2010, . 3918/2011, .4118/2013, . . 6881/2012 ..) - .

.. 4199/2-8-2013 2014, - . . 5239/7-10-2013 , ( !!!) 2014. , 15 .

..... ( .. 486/8-8-2013) ( .. 486/8-8-13), 2014 - .

14/1/2014, 2014 . - .

, - . - , .

2014 -, , - , - , - , .

, - - (AGORA), - !!!

2014 , . , , -, , , - .

7 - - 2013

.....

9 - - 2013

6 .....

:

14-17 2013,

14 2013

15 2013

17.30-19.00:

19.00: . :

19.00-19.30: & ..

19.30-20.00: Roberto Frontini EAHP :

20.00-20.30: ..... :

: 10.00..-15.00.. : ,

: - Evidence Based Practice (E.B.P.) -

:

10.00-10.30: ( , .. ):

10.30-11.00: (MD, , . ):

11.00-11.30: ( , , ): Evidence Based Practice (...) .

11.30-12.00: ( )

12.00-12.30:

6 .....

10

16 2013

12.30-13.00: ( )

13.00-13.30: ( , .. ): (...)

13.30-14.00: ( - Univadis and Online Strategy & Solutions Manager): . UNIVADIS

14.00-15.00: , ,

( .....)

17.30-20.30: ,

17.30-18.30:

18.30-19.00: : ( MSc, )

19.00-19.30:

19.30-20.00: HIV - HIV . : ( - )

20.00-20.30:

: 10.00..-14.30..: ,

10.00-12.00: : / / : . (- BScHS, BScEcon, MSc, PhD) . ( .. . . ) . ( .. ... . )

6 .....

11 - - 2013

11.30-12.00: , ,

12.00-12.30:

12.30-13.30: : , , / : ( , .. .. ) ( , .. .. )

13.30-14.00: ,

14.00-14.30: : . : ... )

-

17.30-20.30: , : :

17.30-17.50: ( ...) ...

17.50-18.10: ( 1 ) ..

18.10-18.30: ( )

18.30-18.50:

18.50-19.10: ( ) ,

19.10-19.30: ( , )

19.30-19.50: (, ...)

19.50-20.30: , ,

17 2013

:

: .. (.....)

09.30-11.00: 6 .....

11.00:

Pfizer Novartis Astellas Glaxo Teva Leo Gilead Vianex Amgen AstraZeneca Elpen SD Baxter Unipharma

Novonordisk Roche Fresenius-Kabi Pharmathen Bayer Takeda Demo Bristol-Myers Squibb Cooper

Vocate Boehringer Ing. Medhel Hellas - Balu Vioser Janssen-Cilag Pharmazac

:

:

:

. :

:

:

: , ,

6 .....

12

13 - 2013

6 .....

6 .....

14

-, , - , ..... . - , - - . , , - , . , , . 124 220

(1/172 2012), 25 . 10 - , .

, , , .

- , , - - .

, - , -, - , - , , .

-

, , , , (- , -, , , - ) - .

- - , (.. - , , , , , - ..) . -, - ..., , .

... 108/93, . 2519/21-8-97 ( 165 ') ... . (>6) .. , - , . - .

- , - (Esynet, Agora, Adam, , be24).

- .

- .

-

.....

15 - - 2013

6 .....

, - - , - -, ... .

..... 108/93 ( ). , ..... - -. - ( ). , -, 6 -, 108/93 . ( 2 ), ..... . - , , -, , ... ! . - , , . , , . - , - ( ) . - - , , , - ... , -

, , - , . - - , - , - - , 10 - - . -, . , - . - , - , - - , .. , . - , , . , , !!! , !

6 .....

16

14-17 2013 6 - . , - , , . - ..., ....

- . - . - .

3 - .

1 , , - . -, ... . EAHP R. Frontini, , - , . .

, . -

, ..... - .

2 : - - (E.B.P.). , . -, ... . , .

, - , .

. , . . - -, - (E.B.P.). , - . - UNIVADIS, - .

, . , - , . , , - . , - ,

17 - - 2013

6 .....

. -, , - - .

- . , - HIV , - , - , - , . .

- 3 : - . , , . , - : ) ( , , ), ) (- , , /DRGS), ) (, - , ).

. . (.. - ) - ( , , , -).

, , , . . - , poster - . , , , -

. Poster PowerPoint.

- , .

- 12 de Octubre - - . : - . . , , - ( -), 12 , - .

, , - .., - .

6 .....

18

:

. , . , .. , . , , ..

: 4 : , , . , , 1995 2013.

: : 768 1655 471 , - .

80,5% , : 19,5% , 43,9% , 0,7% 26,8% . - 2013 1995 (p

19 - - 2013

6 .....

: -

. , . , . , . , .

Cooley . - . , 6-9 .

. , .

, 3.200 , 8% ( 20%). 200 5 . 180 - 20 . , .

. -, , . 102 , , (, , ).

.

:

:

, , -

: INR (International Normalized Ratio)

: :

i. : ( ..), ( ..), ( ..), ( ..), ( ..), ( ).

ii. : ( ..).:

i. : , , ..ii. : , ..

.

:

6 .....

20

: BURNOUT

. , . , .

- . , , .

, , .

, - .

- .

. Maslach, - -.

, , , , - , , , , .., .

- , .

:

,

' 6 .....

,

.

21 - - 2013

6 .....

6

6 .....

22

23 - - 2013

6 .....

:

(...) : -, 18 2013, - .

... .

.

- , ... -

(...) - (..), - .

-, ... , , - , - , .

, , - , : , ,

, -

24

: ...:

25 - - 2013

- .

(, ) - (...) - , - .

- :

-

( ) - -, .

... . - . .. , .

- - .

-, . (- - ) . (- ).

... ( - ) - ... . , . .

. - . ... - , -, ,

...

- , -.

""

26

27 - - 2013

-, , :

:

1) - .. .

2) , - .

3) - .

4) - .

5) .... .

...., - .

-, , - - ( ) . - , , (.. , , - ..).

- , , / .

, , .

:

.. ..

28

-

900 , - . 20-40% -, , .

: , .. .

: , , .

: . . : - (HBV, HCV) , . : - P450 - . - . : .. HIV, , . : - . ( -, ).

Msc

29 - - 2013

-

: , - ( ) . . -

.

(): - , ( 1 1 ). - (.. amoxicillin, clavulanic acid). - .

vs

1 - 6 1 - 1

, ,

) (): . .

ALT > 3ULN & ALT / ALP > 5

) : - (.. -) .

ALP > 2ULN & ALT / ALP < 2

) (/): - .

ALT > 3ULN & ALP > 2ULN & ALT / ALP > 2

:1. . Kaplowitz, Drug-Induced Liver Injury. Clin Inf Diseases 2004;38(2):44-8.2. M.Ghabril, N. Chalasani, E. Bjornsson, Drug-Induced Liver Injury: a clinical update. Curr Opin Gastroenterol 2010;26(3):222-2263. www.gastro.ucsd.edu/.../DrugInducedLiverInjury

:

()

allopurinol, diclofenac, dihydralazine, gemander, halothane, methyldopa, minocycline, nevirapine, phenytoine, propylthiouracil, trovafloxacin

acarbose, amiodarone, bosentan, dantrolene, diclofenac, disulfiram, felbamate, flutamide, HAART, statins, isoniazide, ketoconazole, labetalol, leflunomide, methotrexate, nefazodone, nevirapine, nicotinic acid, paracetamol, pemoline, pyrazinamide, rifampicin, tacrine, tolcapone, troglitazone, sodium valproate, ximelagatran, zafirlukast, zileutin

/

()

-, amitriptilline, amoxicillin/clavulanic acid, carbamazepine chlorpromazine, cotrimoxazole, erythromycin, phenobarbital, sulfonamides, sulindac,

, , azathioprine, cyclosporine, estrogens, terbinafine

/ methotrexate

()

allopurinol, amoxicillin/clavulanic acid, carbamazepine, hydralazine, methyldopa, penicillamine, phenylbutazone, phenytoin, procainamide, quinidine, sylfonamides

nucleoside reverse transcriptase inhibitors, , sodium valproate

,

, danazol

amiodarone, tamoxifen,

amiodarone

Budd-Chiari

Peiliosis Hepatis , , azathioprine

methotrexate, vit.

- busulfan, cyclophosphamide

-

30

31 - - 2013

-

42 - 16-18 2013.

- , -. 3 , .

, PhD - . - . - ( 30 ). .

- :

1. - , .

2. - - ( , - ). - .

3. , -. , -, , - -

, . , . .

-, ESCP (SIGs-Special Interest Groups).

17 , , . .

. , , . - HER2(+) (.. pertuzumab, trastuzumab-DM1).

18 - :

-

-

, , , ..

. - . - - , - . , , , ,

(ESCP) , 16-18 2013

-

32

, .., .

poster :

- . - . -. -. . . . .

, , -, -

, .

:

Msc

Clinical Research Conference: : , 15 & 16 2014, (. 103-105),

5 : : ,

25 26 2014, e-Health, 12-14 2014,

EFGCP Annual Conference 2014: Benefits and Risks of Research: How Do We Redress the Current Imbalance?, 28-29 January 2014, Brussels

1 : ,

30 - 1 2014, , 19o EAHP, 26-28 2014, International Society of Pharmacovigilance (ISOP): Proactive Pharmacovigilance, Risk Management

and Pharmacovigilance in the Era of Personalised Medicine, 3-4 April 2014, Zagreb, Croatia 19 ,

8-11 2014, ,

-

34

9 - , , : 30 . 5-7 - 2013 Hilton . . - , (..), forum (eHealth) 12-14 2014 . . . -, , .., - .

-, - .., . . . - . - eHealth . . , -, - . .

9 () , , 5-7 2013

35 - - 2013

-

- , - , . : - 21 . -, . . , . - . - . . , - . , - . . -, - (), . . . , . - , , check up. , . , - , . - : - , . . - - , ,

, 80% . -: . workshop : - Alma Ata . . . , , - () . . . , , , , - - . , . .

-

36

, . , -. . . - , , . - : -. , . . , - Sanofi, . . . , , - , ... , , - , . , , . . .

(Health Technology Assessment - HTA). - - , - , . , - , . . . - , pay-for-performance . , . - . : , - . , - ex officio . . . , . ... CHMP COMP, - - ,

-

38

, - : ; - . . . , , - - . , . , - , - , - - . : : - . -, 1,5 , - -, ( - ). - . , , . . . , Interamerican - Insurance Europe, . -, ,

. - - - . - . ... / . : - , . . , - Euromedica -, , - , - . . . - . . Ansgar Hebborn, Head market access policy Roche, , , - . - . . . ,

39 - - 2013

-

, . : - ; . , , -, , - . . . , - , - , , . , - . . , . . - - .

- , . , . - . .. - , .. . . . . , - , : Logistics - ., . , . , .-. . : . - ( - ) - . .

: ,

poster 9

9 . , . . : .

-

40

41 - - 2013

-

-

42

(TransAtlantic-TACD): : , , 13 2013

, Trans-Atlantic Consumer Dialogue (TACD) ( ), 13 2013 : - : H .

- , -, , (advocacy capacity-building).

31 2013 : - ; - .

:

:

) (Access to Medicines)

) ) .